| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Lutenizing Hormone
Test CodeCPT Codes
83002
Preferred Specimen
Green
Minimum Volume
Other Acceptable Specimens
Transport Container
Serum (gold top) tube or Lithium Heparin Plasma (green top) tube
Transport Temperature
Specimen Stability
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Methodology
Chemiluminescence
Setup Schedule
Daily upon receipt
Report Available
Reference Range
Female:
Follicular Phase: 2.6-12.1 mIU/mL FOLLICULAR;
Mid-Cycle: 27.3-96.9 mIU/mL MID-CYCLE;
Luteal Phase: 0.8-15.5 mIU/mL LUTEAL;
Post-Menopausal: 13.1-86.5 mIU/mL POST-MENOPAUSE;
Males: 1.3 - 10.5 mIU/mL
Clinical Significance
LH is a dimeric glycoprotein hormone secreted by the anterior pituitary in response to hypothalamic gonadotrophin releasing hormone. The a-subunit is common to other glycoprotein hormones, while the ß-subunit, which confers biological activity, has some homology with that of human chorionic gonadotrophin. During the menstrual cycle, follicle stimulating hormone (FSH) stimulates growth of the ovarian follicle which, when mature, ovulates in response to a surge of LH and, to a lesser extent, of FSH. Ovarian steroids are the primary negative feedback control for LH secretion. At menopause, reduced ovarian negative feedback results in elevated LH concentrations. LH concentrations also tend to be elevated in women of pre-menopausal age who experience ovarian failure, or whose ovaries failed to mature during puberty.